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ABSTRACT
Aureobasidium pullulans is a causal agent of phaeohyphomycosis, occasionally found in men and 
animals. As an agent of different opportunistic fungal processes, it may cause fungemia, systemic 
infections and abscesses in different viscera. This paper aims to report a case of a patient with infec-
tion of the lymphatic system by A. pullulans. A 23-year-old patient being treated for erythema no-
dosum leprosum presented a 60-day complaint of daily fever, hoarseness, odynophagia and weight 
loss. Laboratory tests showed pancytopenia with severe neutropenia, cervical adenomegaly and solid 
contrast uptake lesion in the oropharyngeal region. Due to neutropenia and sepsis the patient was 
initially treated with cefepime and vancomycin, but there was no clinical improvement. Lymph node 
puncture-aspiration showed yeast-form fungus identified as A. pullulans by sequencing ITS region. 
The patient was treated with amphotericin B deoxycholate, leading to complete recovery of bone 
marrow function and regression of adenomegaly and the oropharyngeal lesion.
Keywords: HIV; pneumonia; macrolides; mortality.
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INTRODUCTION
Aureobasidium pullulans is a fungal agent of 
universal distribution, an occasional causing 
agent of phaeohyphomycosis in human beings 
and animals. It is a black yeast-form fungus that 
causes many opportunistic fungal processes and 
owing to its capacity to produce extracellular 
biodegradable polysaccharide pullulan, as well 
as many different hydrolytic enzymes (e.g. am-
ylase, proteinase, cellulase), it is considered an 
agent of great biotechnological importance.1
A. pullulans is an opportunistic agent rarely 
associated with infections in human beings and 
its pathogenic mechanisms are not very well 
known. However, infections located in the most 
varied organic topographies have already been 
associated with the agent, among which there 
are keratomycosis, spleen and mandible abscess-
es, meningitis, skin mycosis and peritonitis.2-6
Systemic fungal infections are relatively com-
mon in patients receiving broad spectrum antibi-
otics, using invasive devices, as well as those im-
munosuppressed. Among febrile neutropenic 
patients, systemic fungal infection is identified 
in about 10% of non-responders to initial anti-
bacterial therapy, and in these patients oppor-
tunistic fungi such as Candida spp. and Asper-
gilus spp. are the isolated agents in 80% to 90% 
of the cases.8 However, rare cases of septicemia 
by A. pullulans have also been reported.5,9-12
The purpose of the present study was to re-
port a case of a patient who had lymphatic sys-
tem lesions which were attributed to infection 
by A. pullulans.
CASE REPORT
Male, 23-year-old patient, coming from Bra-
sília, were being followed up by the Dermatol-
ogy Division, University Hospital of Brasilia. 
The patient had received treatment for lep-
romatous leprosy seven years ago, although 
due to the erythema nodosum leprosum, he 
was still taking thalidomide (200 mg/day) 
and prednisone (5 mg/day) to achieve clini-
cal control. For a period of 60 days the patient 
had been presenting symptoms of daily fe-
ver, hoarseness, odynophagia and weight loss 
which lead to the diagnosis of bacterial phar-
yngotonsillitis. The patient was initially treated 
as an outpatient having received prescription of 
amoxacilin, cephalexin and then clindamycin 
and ciprofloxacin, but with no symptoms relief.
At the hospital admission, the patient was 
markedly asthenic, febrile (39ºC) and had 
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abnormality of vocal timbre. Upon clinical examination, 
he presented significant increase of volume and erythema 
of the palatine tonsils, as well as painful cervical adeno-
megaly. Clinical thoracic and abdominal examination were 
normal, except for dullness to percussion over Traube’s 
space.
Laboratory tests showed a white blood cells count with 
pancytopenia and severe neutropenia, no findings in chest 
x-ray and no liver or kidney abnormalities. Therea! er, the 
detection of febrile neutropenia, in a context of sepsis with 
probable oropharyngeal focus, led to immediate introduc-
tion of antibiotic therapy with cefepime and vancomycin 
(2 g IV BID and 1 g IV BID, respectively). As the patient’s 
health status kept on deteriorating even a! er 48 hours of an-
tibiotics use, and considering that the patient came from a 
kala-azar endemic region, amphotericin B deoxycholate (IV, 
50 mg/day) was associated to the treatment.
Further radiological investigation using CT scan showed a 
contrast-uptake solid lesion, involving the le!  side of the so!  
palate and palatoglossal and palatopharyngeal arches, meas-
uring 30 mm in diameter, associated with multiple non-con-
fluent adenomegaly of bilateral cervical chains (Figure 1). Ab-
dominal CT scan confirmed the clinical findings, showing a 
mild increase in spleen volume. Myelogram showed hypocel-
lular bone marrow with shi!  to the le! , compatible with bone 
marrow aggression, without parasites or fungi in the analyzed 
sample. A rapid rK39 immunochromatographic dipstick test 
(Kala-azar Detect™ Rapid Test, InBios International, Seat-
tle, WA, USA) was also performed and turned out negative. 
Blood cultures did not grow fungal or bacterial agents and 
laryngoscopy revealed no findings suggestive of neoplasm. 
Viral serology (hepatitis B and C, HIV) was negative.
Therefore, cervical lymph node fine needle aspiration 
was undertaken and the analysis of the collected material 
showed presence of many fungal yeast-form structures with 
sprouting that were phagocytized by reticular cells (Figure 2). 
At that time, Paracoccidioidis brasiliensis was ruled out by 
PCR. The culture of the same material revealed growth of 
yeast-form fungal colony, comprised by hyaline septated 
hyphae given rise synchronically to multiple conidia. Some 
attempts were made to define the etiological agent using 
molecular markers. PCR amplification and sequencing of 
intergene region ITS1/2 of gene 18S of the DNA extracted 
from the isolated colony led to the identification of A. pul-
lulans as the putative pathogen. The fragment of sequenced 
ITS region (HUB_PAC1) presented 98% identification with 
the environmental strain of A. pullulans SN22 (GENBANK 
access number: FJ515165), as well as with the clinical strain 
UWFP 769 (GENBANK access number: AY213639), show-
ing a high level of preservation of sequenced nucleotides 
when they were aligned (Figure 3). A! er 30 days of incu-
bation at 35ºC, the fungal colony started to produce a dark 
pigment (Figure 4) with presence of black septated hyphae, 
characteristic of A. pullulans.
The patient progressed with remarkable clinical recovery 
and had remission of fever and neutropenia a! er the 2nd and 
12th day of amphotericin B use, respectively. A! er a total dose 
of 1,850 mg, administered in 40 days, the patient had already 
showed complete remission of adenomegaly and almost 
complete bone marrow recovery, persisting with mild anemia 
(Hb = 11.8g/dL). At that time, the patient was discharged 
using fluconazole at 300 mg, PO, twice a week for 8 weeks. 
Three months a! er the end of treatment, the patient was 
asymptomatic and had complete bone marrow recovery. 
Thalidomide was maintained during the whole period of 
treatment (100 mg/day).
Figure 1: CT scan with contrast of the neck. High-enhanced 
exophytic lesion in the soft palate region on the left. Presence 
of multiple enlarged lymph nodes of the neck chains (*).
Figure 2: Cytology of lymph node aspirate. Many yeast-like 
fungal forms of round and oval shape and varied sizes are 
seen. Some fungal structures demonstrate polar sprouting 
(Grocott; 400X).
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Figure 4: Macroscopy of fungal colony obtained in the material from lymph node aspirate. Yeast-like colonies of beige color, 
with initial points of dark pigment in areas after 30 days of incubation (agar-Sabouraud, 35ºC).
Figure 3: Alignment of sequencing of regions ITS 1/2 of gene 18S A. pullulans. Sequence HUB_PAC1, corresponds to studied 
strain, shows high level of similarity when compared to environmental strain SN22 (GENBANK access number: FJ515165) and 
strain of clinical origin UWFP769 (GENBANK access number: AY213639).
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DISCUSSION
A. pullulans is a saprophyte filamentous fungus of univer-
sal distribution, easily isolated in airborne samples, from 
superficial layers of the ground, domestic waste and leaves 
surface. It is a dematiaceous fungus, which presents colo-
nies of quick growth, preferably at 25ºC, capable of produc-
ing black pigment similar to melanin, which is deposited 
on the cell wall and may act as virulence factor inhibiting 
phagocytosis by the host’s immune system.13 A. pullulans is 
normally considered a contaminant of biological samples, 
but the isolation from sterile sites should be valued given 
that the agent may act as an opportunistic agent.
When isolated in a culture, A. pullulans presents colonies 
initially yeast-form, yellowish, beige or light brown formed 
by dense groups of conidia synchronically originated from 
undifferentiated hyaline hyphae. As a result of maturation 
of colonies, hyphae accumulate pigment and become dark 
brown.7,11 The diagnosis is made by isolation and morpho-
logical characterization in specific culture medium which 
may be successfully studied, but their yeast-form shape may 
be mistaken by other yeasts of Dothideomycete class.2,6
The constant advance of medical science has provided 
increased survival to severely ill patients who in some situ-
ations require aggressive treatments, which commonly lead 
to iatrogenic immunosuppression, the use of invasive intra-
body devices, and the need to use broad spectrum antibac-
terial agents for prolonged periods of time. Nevertheless, 
all those conditions are recognized as risk factor for fungal 
infections and have contributed for the increase in frequen-
cy of infections by opportunistic fungal agents.14 There are 
seven reported cases of systemic disseminated infections by 
A. pullulans as a result of isolation of the agent in blood 
culture. Joshi et al.5 reported a case of a 11-year-old patient 
who had Fanconi anemia and, during the conditioning regi-
men for the performance of bone marrow transplantation, 
because of bone marrow suppression, developed a febrile 
episode followed by cutaneous lesions caused by A. pul-
lulans, which was later isolated in blood culture collected 
from the venous central catheter. Another case was reported 
by Kaczmarski et al.,12 who described a 28-year-old patient 
with acute myeloid leukemia, who had neutropenia second-
ary to chemotherapy and reported isolation of A. pullulans 
in a blood sample collected from Hickman catheter used to 
infuse chemotherapy agents. The involvement of these neu-
tropenic patients, as well as the large proportion of cases of 
peritonitis caused by dialysis catheter infection, confirm the 
role of invasive intrabody devices and immunosuppression 
states as facilitators of these systemic infections.15
In the initial assessment, the significant findings of patient 
were increased volume and erythema of palatine tonsils, cervi-
cal adenomegaly and splenomegaly, associated with hemato-
logical manifestation of pancytopenia. The severe and extensive 
involvement of the lymphohematopoietic system, together with 
absence of clinical improvement a! er 48 hours a! er onset of 
antimicrobials, prompted to the introduction of amphotericin 
B, in addition to broad the possibilities of differential diagnoses.
Clinical data supported by the patient coming from re-
gions endemic of both kala-azar and South-American para-
coccidioidomycosis and also the suspicion of hematological 
neoplasm (lymphoma) or squamous cell carcinoma, led to 
immediate myelogram and lymph node puncture-aspiration 
for diagnostic investigation.
Even though the myelogram had shown neither fun-
gal nor parasite agents or neoplastic findings, mycological 
diagnosis was suggested through fine needle aspiration 
of a cervical lymph node, which showed yeast-like fun-
gal structures with sprouting which were phagocytized by 
host macrophages. From a cytopathology standpoint, ow-
ing to absence of demaceous hyphae in the material, it was 
not possible to define an etiological classification due to 
the similarity of A. pullulans conidia and those of other 
yeast-like fungi.16 In the past, the production of pigment 
was a key factor for the identification of demaceous spe-
cies such as Aureobasidium from culture medium, but 
it is known that this event occurs only as a result of hy-
phae aging, which delays or even causes diagnostic errors. 
In view of these factors, the use of gene sequencing in re-
gions ITS1/2 showed quick and precise etiological diag-
nosis of A. pullulans, which reinforces the e! cacy of this 
method as a diagnostic tool for fungal species, in agree-
ment with the data reported in the literature.17,18
Salkin et al.2 reported a case of fungal invasion of the lym-
phatic system, causing the formation of spleen abscess in a 
patient systematically affected by histiocytic lymphoma. The 
entry of the infection was not identified by the authors, but 
the profound immunesuppression caused by the lymphoma 
seemed to have played a predisposing role in the secondary 
infection by A. pullulans. In another case, disseminated in-
fection of the fungus was reported in a 28-year-old patient 
who had multiple exposed fractures of the le!  femur and 
tibia because of a car accident.11 The exposure of the wounds 
to the ground during the car accident was reported by the 
authors as a likely source of infection, since the ground is 
a known reservoir of the agent. A retrospective analysis of 
our case made us believe that the lesions in the oral mucosa 
could have served as an entry point for the infection in our 
patient, since there were no other specific foci. Moreover, 
immune studies have shown that patients with polar forms 
of lepromatous leprosy and erythema nodosum leprosum 
present a pattern of immune response mediated by Th2 
lymphocytes with the production of IL4 and IL10 cytokines. 
Such cytokines induce the humoral immune response via 
CD8(+) lymphocytes and also seem to lead to negative regu-
lation of Toll-like 2/1 receptors, determining an ineffective 
response against Hansen bacilli.19 Both the history of lep-
romatous leprosy of the patient and the concurrent use of 
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thalidomide at the moment of infection, a drug known for 
its anti-TNF-alpha action, made us advocate that the patient 
might have presented a predominantly humoral immune 
response pattern to A. pullulans. These factors may have fa-
cilitated the dissemination of infection in view of low lev-
els of Th1-type (INF gamma, TNF-alpha) proinflammatory 
cytokines, widely known for their important immune re-
sponse against fungal agents.20
Treatment of A. pullulans infections, either localized 
or disseminated, is not a consensus since up to the pre-
sent day treatment recommendations are based on case re-
ports and case series. In the present case, the total dose of 
1,850 mg of conventional amphotericin B was enough for 
complete remission of cervical adenomegaly and bone mar-
row recovery. Nevertheless, the patient’s prompt recovery 
a! er introduction of the antifungal, even before the isola-
tion of the agent, reinforces the importance of following up 
evidence-based protocols for sepsis management, especially 
in the immunosuppressed or neutropenic hosts.
Therefore, even in the absence of fungal structures visual-
ized in the analysis of bone marrow aspirate, we believe that 
the manifestation of pancytopenia presented by the patient 
may have been secondary to bone marrow invasion by the 
agent. To support this hypothesis, we excluded other infec-
tious agents that may have determined similar clinical and 
laboratory manifestations. Alternatively, medications such 
as clindamycin,21 ciprofloxacin,22 and thalidomide23 had been 
associated with episodes of bone marrow suppression, but 
considering the rarity of these reports and the complete he-
matological recovery of the patient, even during maintenance 
of thalidomide, we think it is unlikely that the manifestation 
of marrow suppression had been an adverse reaction to the 
use of these drugs.
The di! culty to define the diagnosis of A. pullulans 
infection, as reported by us and other contemporary au-
thors,15,16 owing to agent polymorphism or the large range 
of differential diagnoses, has confirmed the great value of 
molecular biology as a diagnostic tool.
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